Drugs / Envacgen®
last change Jul 2026 re-read 3 minutes ago

Envacgen®

Vaccine

Investigated by
Medigen Vaccine Biologics Corp.

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Filed Other — enterovirus antenatal infection 2023-05-24

“向越南藥品管理局(Drug Administration of Vietnam, DAV)提交「高端腸病毒71型疫苗(Envacgen)」之新藥查驗登記審查申請” medigenvac.com ↗

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07178522 Jun 2025 → Jul 2026 overdue — Medigen Vaccine Biologics Corp. Active not recruiting No outcome recorded

News releases announcing trial results or a regulatory action · 3

DateIssuerRelease
2026-03-18 Medigen Vaccine Biologics Corp. Regulatory 高端恩穩健成功取得越南首張腸病毒71型疫苗藥證 com.tw ↗
恩穩健(ENVACGEN®)腸病毒71型(EV-A71)疫苗已正式取得越南藥品管理局(DAV)核發之藥品上市許可。
2026-03-17 Medigen Vaccine Biologics Corp. Regulatory 高端恩穩健成功取得越南首張腸病毒71型疫苗藥證,攜手Substipharm Biologics拓展東南亞商業布局 medigenvac.com ↗
高端疫苗生物製劑股份有限公司(MVC)與 Substipharm Biologics 今日 (2026/03/17) 共同宣布,恩穩健(ENVACGEN®)腸病毒71型(EV-A71)疫苗已正式取得越南藥品管理局(DAV)核發之藥品上市許可。
2023-05-24 Medigen Vaccine Biologics Corp. Regulatory 高端腸病毒EV71型疫苗於越南提交新藥查驗登記 medigenvac.com ↗
高端疫苗公司於今日(5/24)向越南藥品管理局(Drug Administration of Vietnam, DAV)提交「高端腸病毒71型疫苗(Envacgen)」之新藥查驗登記審查申請;後續並規劃繼續向東南亞以及其他目標市場之藥政法規單位提出新藥查驗登記程序,積極拓展市場。

All press releases naming this drug 3 releases

DateIssuerRelease

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Envacgen ClinicalTrials.gov intervention name — accepted as the source's own label NCT07178522 ↗
Modality Vaccine “Inactivated EV71 Enterovirus Vaccine” NCT07178522 ↗
Route Intramuscular “0.5 mL IM injection” NCT07178522 ↗